Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Lipoprotein(a) Foundation Hosts Gala Fundraiser to Celebrate Opening of Lipoprotein Exhibition at the International Museum of Surgical Science

The Lipoprotein(a) Foundation
Posted on: 07 Nov 18

The Lipoprotein(a) Foundation:

WHAT:

     

The Lipoprotein(a) Foundation is hosting a Gala Fundraiser to celebrate the opening of the “Understanding Lipoproteins: Research, Treatment and Relationship to Cholesterol” exhibition at the International Museum of Surgical Science (IMSS)

∙ All proceeds from the Hope Gala go to support the REVEAL Lipoprotein(a) Patient Natural History Registry to further Lp(a) research

∙ Sponsored by Amgen, Inc., Akcea Therapeutics, Denka Seiken, Arrowhead Pharmaceuticals, Kaneka Corporation and IONIS Pharmaceuticals

∙ The Hope Gala will showcase the “Understanding Lipoproteins” Exhibition, which is dedicated to pioneering University of Chicago researcher, Angelo M. Scanu, M.D.

Hope Gala Press Release

 

WHEN:

The Hope Gala: Lp(a) Research From the Bench to the Clinic: Reflections on the Past, the Present and the Future takes place on Saturday, November 10 at 7pm

∙ The “Understanding Lipoproteins” exhibit opens to the public on Monday, November 12

Hope Gala Registration

 

WHERE:

International Museum of Surgical Science (IMSS)

1524. N. Lake Shore Drive, Chicago, IL

 

WHY:

The “Understanding Lipoproteins” exhibit reviews the health impact of lipoproteins, particles in the blood that carry what is often referred to as “bad” and “good” cholesterol

∙ It is estimated that 63 million in the US have inherited high Lp(a)

∙ Lp(a) concentrations can be measured by a simple blood test, but it is not included in most standard lipid panel tests that check cholesterol levels

∙ A study published in JACC shows that the current cholesterol screening will miss 8% of people who have a cardiovascular event whose only risk factor is high Lp(a)

 

WHO:

The following cardiovascular event survivors and cardiovascular disease experts are available to discuss hereditary risks of cardiovascular disease associated with Lp(a):

∙ Sandra Revill Tremulis, survivor and founder of Lipoprotein(a) Foundation

∙ Celina Edelstein, University of Chicago research scientist and Dr Scanu’s colleague

∙ Henry Ginsberg, MD Columbia College of Physicians and Surgeons and Chief Medical Officer for The Lipoprotein(a) Foundation

∙ Monica Stokes, International Museum of Surgical Science

View source version on businesswire.com: https://www.businesswire.com/news/home/20181109005006/en/

Business Wire
www.businesswire.com

Last updated on: 09/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.